GINKGO BIOWORKS HOLDINGS, INC. (DNA)

Healthcare · Biological Products, (No Diagnostic Substances) · Price $6.96
Updated: Sep 1, 2026
Operating Income (TTM)
$-290.7M
Trailing 12 Months
Growth Rate
N/A
Log-Linear Regression (0Q)
Operating Margin
-259.86%
Operational Efficiency
EV/Operating Income
N/A
Valuation Multiple
Net Income
$-290.8M
After Interest & Taxes

🧮 DNA Operating Income Breakdown

Operating Income = Gross Profit - Operating Expenses (SG&A, R&D, etc.)
Revenue (Top Line) $111.9M
Less: Cost of Revenue → Gross Profit $440.6M
Equals: Operating Income (EBIT) $-290.7M
Then: Less Interest & Taxes → Net Income $-290.8M

Understanding Operating Income

Operating Income, also known as EBIT (Earnings Before Interest and Taxes), measures a company's profit from its core business operations before financing costs and taxes. For DNA, the trailing twelve month operating income is $-290.7M.

Why Operating Income Matters

Operating income isolates business performance from capital structure decisions (debt vs equity financing) and tax strategies. This makes it ideal for comparing companies with different debt levels or tax situations. It shows how efficiently management runs the core operations.

DNA's operating income growth rate of N/A (based on log-linear regression of 0 quarters) indicates relatively flat or slightly declining operational performance.

Operating Income vs Other Profitability Metrics

Net Income: $-290.8M →

The bottom line after interest and taxes. Net income shows the final profit, while operating income excludes financing decisions.

Free Cash Flow: $-168.2M →

Actual cash generated after capital expenditures. FCF can differ significantly from operating income due to working capital and capex.

Owner Earnings: $-168.2M →

Buffett's measure of true cash generation. Adds back depreciation and subtracts only maintenance capex.

Revenue: $111.9M →

The top line that operating income is derived from. Operating margin shows what percentage becomes operational profit.

Operating Margin Analysis

DNA's operating margin of -259.86% shows what percentage of revenue converts to operating profit after all operating expenses. Negative operating margins indicate the company is losing money on core operations.

EV/Operating Income Valuation

The EV/Operating Income ratio is not available for this company.

Summary: DNA Operating Income Trend

GINKGO BIOWORKS HOLDINGS, INC. (DNA) has a negative operating margin of -259.86% — the business is currently loss-making at the operating level. Operating income trend: N/A annually — a negative trend — revenue erosion that warrants monitoring. For complete financial analysis, view the full DNA stock report on Zyberno.

Frequently Asked Questions

What is DNA's current operating income?

GINKGO BIOWORKS HOLDINGS, INC.'s TTM operating income is $-290.7M, growing at N/A annually — a negative trend — revenue erosion that warrants monitoring.

Is DNA's operating income growing?

GINKGO BIOWORKS HOLDINGS, INC. (DNA) has a negative operating margin of -259.86% — the business is currently loss-making at the operating level. Operating income trend: N/A annually — a negative trend — revenue erosion that warrants monitoring.

What is DNA's operating margin?

GINKGO BIOWORKS HOLDINGS, INC. (DNA) has a negative operating margin of -259.86% — the business is currently loss-making at the operating level. Operating income trend: N/A annually — a negative trend — revenue erosion that warrants monitoring.

What is the difference between operating income and EBIT?

Operating income and EBIT (Earnings Before Interest and Taxes) are generally the same metric - both measure profit from core operations before financing costs and taxes. DNA's EBIT/Operating Income is $-290.7M.

How does operating income differ from net income?

Operating income excludes interest expense and income taxes, while net income includes them. DNA's operating income is $-290.7M versus net income of $-290.8M. The difference reflects financing costs and tax burden.

📊 Valuation Trilogy
Three interconnected metrics built on Owner Earnings
💎
Intrinsic Value
DCF Fair Value
🛡️
Margin of Safety
Valuation Gap
🎯
Expected Return
Projected Annual
Click any metric for full methodology and detailed analysis

📊 Full DNA Stock Report

See DNA's intrinsic value, margin of safety, DCF valuation, and complete financial analysis with 250+ metrics.

💵 DNA Free Cash Flow

Compare to Free Cash Flow which subtracts all capital expenditures, not just maintenance CapEx.

💰 DNA Owner Earnings

Compare to Buffett's Owner Earnings metric which uses maintenance CapEx instead of total capital expenditures.

📈 DNA Earnings Per Share

Analyze EPS trends, P/E ratio, earnings yield, and per-share profitability metrics.

🎯 DNA Earnings Surprise (SUE)

See whether DNA is beating or missing its own earnings trend — Standardized Unexpected Earnings and post-earnings drift.

📊 DNA Revenue

Analyze revenue trends, growth rate, P/S ratio, and top-line sales performance.

💰 DNA Net Income

Analyze the bottom-line profit, P/E ratio, and net profit margin trends.

🔶 DNA Operating Income

Analyze EBIT, operating margin, and core business profitability before interest and taxes.

💜 DNA Gross Profit

Analyze gross margin, pricing power, and profitability before operating expenses.

View Full DNA Report Find More Quality Stocks
Scroll to Top